Rational use of analgesic and antiinflammatory drugs. Crofford LJ (2001) N Engl J Med 345: 1844-6 Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases. Rouzer CA, Marnett LJ (2003) Chem Rev 103: 2239-304 Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways. Rouzer CA, Marnett LJ (2011) Chem Rev 111: 5899-921 COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR (2002) Lancet 360: 1071-3 Neurosensory perception of environmental cues modulates sperm motility critical for fertilization. McKnight K, Hoang HD, Prasain JK, Brown N, Vibbert J, Hollister KA, Moore R, Ragains JR, Reese J, Miller MA (2014) Science 344: 754-7 Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Kalgutkar AS, Crews BC, Rowlinson SW, Garner C, Seibert K, Marnett LJ (1998) Science 280: 1268-70 Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, Kawaguchi Y, Johann D, Liotta LA, Crawford HC, Putt ME, Jacks T, Wright CV, Hruban RH, Lowy AM, Tuveson DA (2003) Cancer Cell 4: 437-50 Human lupus T cells resist inactivation and escape death by upregulating COX-2. Xu L, Zhang L, Yi Y, Kang HK, Datta SK (2004) Nat Med 10: 411-5 COX-2: a target for colon cancer prevention. Marnett LJ, DuBois RN (2002) Annu Rev Pharmacol Toxicol 42: 55-80 Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, Riendeau D, Marnett LJ, Morrow JD, Fazio S, Linton MF (2002) Circulation 105: 1816-23 Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Hennan JK, Huang J, Barrett TD, Driscoll EM, Willens DE, Park AM, Crofford LJ, Lucchesi BR (2001) Circulation 104: 820-5 Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. Dixon DA, Balch GC, Kedersha N, Anderson P, Zimmerman GA, Beauchamp RD, Prescott SM (2003) J Exp Med 198: 475-81 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Gastroenterology 107: 1183-8 Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins. Callejas NA, Boscá L, Williams CS, DuBOIS RN, Martín-Sanz P (2000) Gastroenterology 119: 493-501 Elevated cyclooxygenase-2 levels in Min mouse adenomas. Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD, DuBois RN (1996) Gastroenterology 111: 1134-40 Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Mann M, Sheng H, Shao J, Williams CS, Pisacane PI, Sliwkowski MX, DuBois RN (2001) Gastroenterology 120: 1713-9 A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Sheng GG, Shao J, Sheng H, Hooton EB, Isakson PC, Morrow JD, Coffey RJ, DuBois RN, Beauchamp RD (1997) Gastroenterology 113: 1883-91 Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice. Shattuck-Brandt RL, Varilek GW, Radhika A, Yang F, Washington MK, DuBois RN (2000) Gastroenterology 118: 337-45 Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, Wilson KT (1999) Gastroenterology 116: 1319-29 Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN (1997) J Clin Invest 99: 2254-9 Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. Hao CM, Yull F, Blackwell T, Kömhoff M, Davis LS, Breyer MD (2000) J Clin Invest 106: 973-82 In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. Sano H, Hla T, Maier JA, Crofford LJ, Case JP, Maciag T, Wilder RL (1992) J Clin Invest 89: 97-108 Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters-Golden M (1995) J Clin Invest 95: 1861-8 Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. Adler DH, Cogan JD, Phillips JA, Schnetz-Boutaud N, Milne GL, Iverson T, Stein JA, Brenner DA, Morrow JD, Boutaud O, Oates JA (2008) J Clin Invest 118: 2121-31 Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. Crofford LJ, Wilder RL, Ristimäki AP, Sano H, Remmers EF, Epps HR, Hla T (1994) J Clin Invest 93: 1095-101 Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. DuBois RN, Awad J, Morrow J, Roberts LJ, Bishop PR (1994) J Clin Invest 93: 493-8 Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD (1994) J Clin Invest 94: 2504-10 Aspirin use and potential mechanisms for colorectal cancer prevention. Williams CS, Smalley W, DuBois RN (1997) J Clin Invest 100: 1325-9 Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD (2002) J Clin Invest 110: 61-9 Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. Morrow JD, Awad JA, Kato T, Takahashi K, Badr KF, Roberts LJ, Burk RF (1992) J Clin Invest 90: 2502-7 Angiotensin II attenuates renal cortical cyclooxygenase-2 expression. Cheng HF, Wang JL, Zhang MZ, Miyazaki Y, Ichikawa I, McKanna JA, Harris RC (1999) J Clin Invest 103: 953-61 Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. Cheng HF, Wang JL, Zhang MZ, McKanna JA, Harris RC (2000) J Clin Invest 106: 681-8 Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. Yang L, Yamagata N, Yadav R, Brandon S, Courtney RL, Morrow JD, Shyr Y, Boothby M, Joyce S, Carbone DP, Breyer RM (2003) J Clin Invest 111: 727-35 Host cyclooxygenase-2 modulates carcinoma growth. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN (2000) J Clin Invest 105: 1589-94 Cyclooxygenase inhibition abrogates aeroallergen-induced immune tolerance by suppressing prostaglandin I2 receptor signaling. Zhou W, Goleniewska K, Zhang J, Dulek DE, Toki S, Lotz MT, Newcomb DC, Boswell MG, Polosukhin VV, Milne GL, Wu P, Moore ML, FitzGerald GA, Peebles RS (2014) J Allergy Clin Immunol 134: 698-705.e5 Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease. Shi J, Wang Q, Johansson JU, Liang X, Woodling NS, Priyam P, Loui TM, Merchant M, Breyer RM, Montine TJ, Andreasson K (2012) Ann Neurol 72: 788-98 Prednisone increases PGH-synthase 2 in atopic humans in vivo. Dworski RT, Funk CD, Oates JA, Sheller JR (1997) Am J Respir Crit Care Med 155: 351-7 Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases. Boutaud O, Aronoff DM, Richardson JH, Marnett LJ, Oates JA (2002) Proc Natl Acad Sci U S A 99: 7130-5 Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids. Zhang MZ, Harris RC, McKanna JA (1999) Proc Natl Acad Sci U S A 96: 15280-5 Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors. Kalgutkar AS, Crews BC, Rowlinson SW, Marnett AB, Kozak KR, Remmel RP, Marnett LJ (2000) Proc Natl Acad Sci U S A 97: 925-30
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.